Want to see SE:PTRK full AI Analyst Report?

Physitrack Limited (PTRK) Price & Analysis

1 Followers

PTRK Stock Chart & Stats

kr8.06

kr0.26(3.23%)

At close: Jul 27 4:00 PM EDT

kr8.06

kr0.26(3.23%)

Day’s Range― - ―

52-Week Rangekr7.36 - kr21.70

Previous CloseN/A

Volume42.99K

Average Volume (3M)49.62K

Market Cap

kr133.66M

Enterprise Valuekr168.38

Total Cash (Recent Filing)kr398.16K

Total Debt (Recent Filing)kr4.28M

Price to Earnings (P/E)―

Beta0.76

Next Earnings

Oct 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.51

Shares Outstanding16,260,765

10 Day Avg. Volume41,844

30 Day Avg. Volume49,617

Financial Highlights & Ratios

PEG Ratio-0.57

Price to Book (P/B)1.97

Price to Sales (P/S)1.42

P/FCF Ratio5.09

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)kr13.80M

Bulls Say, Bears Say

Bulls Say

Positive Cash GenerationPositive operating and free cash flow despite reported net losses indicates the platform is currently converting activity into cash. If maintained, this supports ongoing operations and product investment without relying as heavily on external funding.

Manageable LeverageModerate leverage limits the balance-sheet burden relative to a highly debt-funded software business. This provides greater financial flexibility while management works to restore revenue growth and improve profitability.

Positive EBITDA MarginA positive EBITDA margin suggests the core operating platform can generate earnings before non-operating and below-the-line costs. This provides a foundation for eventual bottom-line recovery if revenue stabilizes and losses narrow.

Bears Say

Severe Revenue ContractionThe sharp revenue decline is the most serious fundamental weakness because recurring software economics depend on retaining and expanding customers. Continued contraction would reduce operating scale, weaken investment capacity, and pressure future margins.

Persistent Net LossesDeep net losses and strongly negative returns on equity indicate that positive EBITDA is not yet translating into shareholder value. Persistent losses can erode capital, constrain strategic investment, and increase dependence on continued cash-flow improvement.

Volatile Cash-Flow HistoryThe recent cash surplus is encouraging but has not yet demonstrated a stable multi-year pattern. Prior negative free cash flow raises the risk that current cash generation may reverse, limiting confidence in self-funded growth and financial resilience.

PTRK FAQ

What was Physitrack Limited’s price range in the past 12 months?

Physitrack Limited lowest stock price was kr7.36 and its highest was kr21.70 in the past 12 months.

What is Physitrack Limited’s market cap?

Physitrack Limited’s market cap is kr133.66M.

When is Physitrack Limited’s upcoming earnings report date?

Physitrack Limited’s upcoming earnings report date is Oct 20, 2026 which is in 57 days.

How were Physitrack Limited’s earnings last quarter?

Physitrack Limited released its earnings results on Jul 21, 2026. The company reported -kr0.111 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Physitrack Limited overvalued?

According to Wall Street analysts Physitrack Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Physitrack Limited pay dividends?

Physitrack Limited does not currently pay dividends.

What is Physitrack Limited’s EPS estimate?

Physitrack Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Physitrack Limited have?

Physitrack Limited has 16,260,765 shares outstanding.

What happened to Physitrack Limited’s price movement after its last earnings report?

Physitrack Limited reported an EPS of -kr0.111 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 10.283%.

Which hedge fund is a major shareholder of Physitrack Limited?

Currently, no hedge funds are holding shares in SE:PTRK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Physitrack Limited

Physitrack PLC operates globally as a digital healthcare innovator. The company delivers a proprietary cloud-based Software-as-a-Service (SaaS) platform, utilized by a diverse range of healthcare providers, from individual practitioners to large organizations, to completely digitalize the patient journey—from their initial contact through ongoing interactions and tracking of progress. Additionally, Physitrack offers virtual care solutions that address three key areas for patients and insurance plan members: preventive and wellness support, care for acute and chronic conditions, and surgical recovery. These virtual care services are supplied to healthcare enterprises such as private and public hospitals, clinics, and other health businesses. Founded in 2012, the company was formerly known as Physitrack Limited before rebranding to Physitrack PLC in May 2021 and is based in London, United Kingdom.